60 Degrees Pharmaceuticals, Inc.
SXTP
$1.61
-$0.03-1.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -36.75% | 16.24% | 256.92% | 144.95% | 89.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -36.75% | 16.24% | 256.92% | 144.95% | 89.43% |
| Cost of Revenue | -17.32% | 3.77% | 28.11% | -90.58% | 10.31% |
| Gross Profit | -9.21% | 3.61% | 9.37% | 100.26% | 29.74% |
| SG&A Expenses | 9.68% | -8.18% | 23.99% | 42.78% | 60.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.15% | -4.44% | 25.91% | -55.67% | 46.65% |
| Operating Income | -9.63% | 7.16% | -9.76% | 61.69% | -42.35% |
| Income Before Tax | -11.34% | 29.70% | -7.25% | 58.47% | -538.62% |
| Income Tax Expenses | -- | -125.00% | 0.00% | 275.00% | -- |
| Earnings from Continuing Operations | -11.34% | 29.76% | -7.24% | 58.44% | -538.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 12.50% | -87.18% | 0.00% | -20.00% | -68.00% |
| Net Income | -11.33% | 29.65% | -7.25% | 58.45% | -535.89% |
| EBIT | -9.63% | 7.16% | -9.76% | 61.69% | -42.35% |
| EBITDA | -9.24% | 7.59% | -9.44% | 62.06% | -42.01% |
| EPS Basic | 79.36% | 83.86% | 85.72% | 94.02% | -183.90% |
| Normalized Basic EPS | 79.30% | 84.20% | 85.74% | 94.28% | -157.09% |
| EPS Diluted | 79.36% | 83.86% | 85.72% | 94.02% | -183.90% |
| Normalized Diluted EPS | 79.30% | 84.20% | 85.74% | 94.28% | -157.09% |
| Average Basic Shares Outstanding | 437.80% | 346.15% | 651.96% | 626.23% | 660.43% |
| Average Diluted Shares Outstanding | 437.80% | 346.15% | 651.96% | 626.23% | 660.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |